Corbus Pharma (NASDAQ: CRBP) reported Q4 EPS of ($0.28), versus ($0.13) reported last year. Revenue for the quarter came in at $648.4 thousand, versus $0 reported last year.

For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.